Coronavirus and SARS-CoV-2

Coronavirus disease (COVID-19) is a new infection and virulent respiratory disease occurs when virus-containing particles expired by an infected person, either respiratory droplets or aerosols effectuated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an uncommon severe acute respiratory syndrome coronavirus. Although SARS-CoV-2 has a response for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyper inflammation. The virus predominantly spreads between people through close contact and by means of respiratory droplets induced from coughs or sneezes and it mainly enters human cells by binding to the receptor angiotensin converting enzyme 2.

Most common symptoms are:

  • Fever
  • Dry cough
  • Tiredness

Related Conference of Coronavirus and SARS-CoV-2

July 11-12, 2022

International Conference on Vaccine Research

London, UK
July 13-14, 2022

International Conference on Immunology

London, UK
August 22-23, 2022

4th World Congress on Vaccine and Immunology

Toronto, Canada
August 24-24, 2022

3rd International Conference on Immunology & Immunotherapies

Singapore City, Singapore
August 24-24, 2022

17th International Conference on Allergy and Clinical Immunology

Singapore City, Singapore
September 16-16, 2022

4th World Conference on Vaccine and Immunology

Osaka, Japan
September 16-17, 2022

International Conference on Immunology Research

New York, USA
November 17-18, 2022

World Congress on Infectious and Contagious Disease

Berlin, Germany

Coronavirus and SARS-CoV-2 Conference Speakers

Recommended Sessions

Related Journals

Are you interested in